Anatara abroad

Townsville Bulletin - - NEWS -

BIOTECH Anatara Life­sciences, which is work­ing to treat di­ar­rhoea in farm an­i­mals, is set to tar­get mar­kets in Europe and the US. The biotech has raised $ 9 mil­lion from in­vestors, with the funds go­ing to­wards in­ter­na­tional reg­is­tra­tion and fur­ther de­vel­op­ment of Anatara’s lead prod­uct, De­tach. De­tach is a nat­u­ral, nonan­tibi­otic treat­ment for di­ar­rhoea in pigs and other farm an­i­mals. “The com­bined $ 9 mil­lion raised will al­low Anatara to move into both Europe and the US mar­kets in par­al­lel, as well as tar­get the larger Asian mar­kets ear­lier than orig­i­nally forecast,” chair­man Dr Mel Bridges said.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.